News

1/29/2024

Cryosa, Inc. announces First patient treated in the U.S. for Obstructive Sleep Apnea (OSA).

9/23/2021

Cryosa Closes $21.5 Million Series B Funding Round to Advance Minimally Invasive Obstructive Sleep Apnea Treatment

6/25/2020

Cryosa Completes $8.25 Million in Series A-2 Funding for Further Development of Breakthrough, Minimally Invasive Treatment for Obstructive Sleep Apnea